Sign in

CIK 0001082554 · Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
521984749
Phone
3016089292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$347,711,405
in 75 filings, $346.9M under 10b5-1 plans

Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROTHBLATT MARTINE A −$320.2M Chairperson & CEO sold 65% of stake
  2. MAHON PAUL A −$26.6M EVP & GENERAL COUNSEL sold 52% of stake
  3. PATUSKY CHRISTOPHER −$702K Director sold 36% of stake
  4. Mesa Nilda −$115K Director sold 4% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 PATUSKY CHRISTOPHER Director Option exercise +1,210 $132.30 $160K 3,350
2026-11-09 PATUSKY CHRISTOPHER Director Sale −1,210 $580.00 $702K 2,140
2026-11-09 PATUSKY CHRISTOPHER Director Option exercise · Stock Option −1,210 3,000
2026-07-22 PATUSKY CHRISTOPHER Director Grant or award · Stock Option +2,380 2,380
2026-07-09 PATUSKY CHRISTOPHER Director Option exercise +650 2,140
2026-07-09 PATUSKY CHRISTOPHER Director Option exercise · Restricted Stock Unit −650 0
2026-04-24 PATUSKY CHRISTOPHER Director Option exercise 10b5-1 +2,910 $101.80 $296K 4,400
2026-04-24 PATUSKY CHRISTOPHER Director Sale 10b5-1 −2,910 $569.00 $1.7M 1,490
2026-04-24 PATUSKY CHRISTOPHER Director Option exercise · Stock Option 10b5-1 −2,910 0

Page 1 of 1 · 9 trades